Sign inJoin waitlistJoin the waitlist

Alex Mohler

Director of the VICC Neurofibromatosis Clinic; Vanderbilt University Medical Center · University of Alabama Hospital

Credentials: · · · · · ·

History

Vanderbilt University Medical Center
Present
University of Alabama Hospital
Present

University of Colorado School of Medicine
2013–2015
Neurology
University of Colorado School of Medicine
2011–2014
University of Colorado Hospital
2011–2014
University of Colorado Hospital
2010–2011
Georgetown University in Washington, DC
USF Health Morsani College of Medicine
2006–2010

Research

Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma: BrUOG329, A Phase I Brown University Oncology Research Group Trial
American Journal of Clinical Oncology · 2021 · 19 citations
Pulsed-Reduced Dose Rate (PRDR) Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results
Cancers · 2022 · 7 citations
Comparative evaluation of the diagnostic and prognostic performance of CNSide™ versus standard cytology for leptomeningeal disease
Neuro-Oncology Advances · 2024 · 6 citations

Minesh Mehta
3 papers
Patrick Kelly
3 papers
RK
Rupesh Kotecha
3 papers
Ryan Merrell
3 papers
Yazmin Odia
3 papers
Bret Mobley
2 papers
Colin McKnight
2 papers
Douglas Ney
2 papers
Elizabeth Maher
2 papers
Julia Berry
2 papers · 1 as a fellow
Larry Davis
2 papers
Leo Luo
2 papers

Clinical trials

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Site PI · Recruiting · Phase 1
National Cancer Institute (NCI)
2025–2027
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Site PI · Recruiting · Phase 1, Phase 2
Neonc Technologies, Inc.
2023–2027